Pretransplantation therapy with hypomethylating agents in patients with myelodysplastic syndromes receiving reduced-intensity conditioning regimens

Biol Blood Marrow Transplant. 2014 Sep;20(9):1260-1. doi: 10.1016/j.bbmt.2014.07.006. Epub 2014 Jul 11.

Authors

Matteo Giovanni Della Porta¹, Emilio Paolo Alessandrino²

Affiliations

¹ Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Internal Medicine, University of Pavia, Italy.
² Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: [email protected].

PMID: 25020100
DOI: 10.1016/j.bbmt.2014.07.006

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antimetabolites, Antineoplastic / therapeutic use*
Azacitidine / therapeutic use*
Female
Hematopoietic Stem Cell Transplantation / methods*
Humans
Male
Myelodysplastic Syndromes / therapy*
Transplantation Conditioning / methods*
Transplantation, Homologous / methods*

Substances

Antimetabolites, Antineoplastic
Azacitidine